Tag Archive: CTL019

Dec 19 2014

Benefits Persist in T Cell Therapy for Children with Relapsed Leukemia

leukemiaAn innovative cell therapy for this stubborn form of leukemia continues to show highly promising results in children treated in a pilot clinical trial.

Read the rest of this entry >>

Oct 20 2014

T-Cell Therapy Leads to Remission in 90 Percent of Leukemia Patients

leukemiaA landmark new study published in the New England Journal of Medicine shows that 90 percent of leukemia patients treated with a groundbreaking form of cellular therapy achieved complete responses.

Read the rest of this entry >>

May 6 2014

Blocking Paths to Resistance to T Cell Therapy for B-ALL

B-ALLCHOP’s Center for Childhood Cancer Research (CCCR), has begun a unique collaboration that will contribute to scientific understanding of how immunotherapy can improve the survival of children with B cell acute lymphoblastic leukemia (B-ALL) that resists standard therapy.

Read the rest of this entry >>

Dec 9 2012

Leukemia Patient Cancer-Free After Novel Treatment With Engineered Immune Cells

Emma relapses with acute lymphoblastic leukemia

Dr. Stephen Grupp's patient, Emma, relapses with acute lymphoblastic leukemia (ALL) in April 2011.

Cancer therapy for children has come a long way over the last several decades, and the cure rate for some forms of pediatric cancer is at an all-time high. Although this success rate offers tremendous hope and optimism, there are some children whose disease fails to respond to conventional treatment, leaving doctors to explore novel ways to conquer cancer.

Read the rest of this entry >>